HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Alkem Laboratories launches Ginsenoside Exosome-based hair growth serum ‘Renocia Exo’
Sep-08-2026

Alkem Laboratories has launched Renocia Exo, a next-generation hair regeneration therapy developed to support the health and vitality of the hair follicle through a comprehensive scientific approach. Inspired by regenerative dermatology, Renocia Exo offers a new multitargeted approach to hair loss management by supporting the biology of the hair follicle-not just hair growth. The formulation integrates Ginsenoside phyto-exosomes, biomimetic peptides, copper peptides and stem cell-supportive actives to support follicular vitality, scalp health and the natural hair growth cycle.

Unlike conventional topical approaches that primarily focus on stimulating visible hair growth, Renocia Exo has been developed to support several interconnected biological processes associated with healthy hair follicle function.

The formulation also focuses on supporting multiple signalling pathways involved in hair follicle activity while promoting a favourable environment for healthier, stronger hair over time. Its lightweight, cosmetically elegant composition is free from alcohol, sulphates, silicones parabens and mineral oil, making it suitable for regular use as part of dermatologist-guided hair loss management.

Alkem Laboratories is among India’s leading global pharmaceutical companies. The company develops, manufactures and markets high-quality pharmaceutical products across all major therapeutic segments.

  RELATED NEWS >>